Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 148   

Articles published

BMY 51.12 +0.24 (0.47%)
price chart
Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
Bristol-Myers Squibb (NYSE: BMY ) fell hard off the patent cliff following the loss of exclusivity for its top-selling blood thinner Plavix.
Bristol-Myers Squibb EVP Unloads $3232374 in Stock (BMY)  Intercooler
Bristol-Myers Squibb COO Sells $1331080 in Stock (BMY)  Mideast Time
Related articles »  
Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer ...
Bristol-Myers expects a decision from the Food and Drug Administration on its nivolumab skin cancer treatment in mid 2015. The suit, filed Thursday in federal court in Wilmington, Delaware, is Bristol-Myers Squibb v. Merck & Co., 14-cv-01131, U.S ...
Daily Options Trading for Bristol-Myers Squibb Company (BMY)  AVAFIN
Bristol-Myers Squibb Challenges Patent on Merck's Pembrolizumab  OncLive
Related articles »  
Stocks to Watch: Cisco Systems (NASDAQ:CSCO), Bristol-Myers Squibb ...
Bristol-Myers Squibb Company (NYSE:BMY)'s board of directors declared a quarterly dividend of thirty-six cents ($0.36) per share on the $.10 par value Common Stock of the corporation.
Bristol-Myers Squibb Co (BMY) Sues Merck & Co., Inc. (MRK) Over Cancer Drug ...
Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc. (NYSE:MRK) last Thursday, claiming that the company's new cancer drug Keytruba (which was approved by the FDA the same day) violates ...
Weekly Pharma Notes: Bristol-Myers Squibb, Johnson & Johnson, Merck And ...  Forbes
Volatile Stocks to Watch: Bristol-Myers Squibb Co (NYSE:BMY), Energy ...  Techsonian (press release)
Related articles »  
Deutsche Bank Starts Bristol-Myers Squibb Co. (BMY) at Hold
Deutsche Bank initiated coverage on Bristol-Myers Squibb Co. (NYSE: BMY) with a Hold rating and a price target of $52.00. Analyst Gregg Gilbert said, "We are initiating coverage of Bristol Myers Squibb (BMY) with a Hold rating and $52 target price.
Shining on Major News: Bristol-Myers Squibb Company (NYSE:BMY), Best Buy ...  WallStreet Scope
Bristol-Myers Squibb Receives Buy Rating from TheStreet (BMY)  WKRB News
Related articles »  
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's "Storm The Castle ...
Trade-Ideas LLC identified Bristol-Myers Squibb Company ( BMY) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate.
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen ...
In Bristol-Myers Squibb Co (NYSE:BMY), Orbimed Advisors revealed holding 7.19 million shares, worth nearly $349 million. The stake represents an increase from 5.97 million shares the fund reported previously.
Related articles »  
Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) � Bristol-Myers ...
Bristol-Myers Squibb Company (NYSE:BMY) [Business Wire] - Bristol-Myers Squibb Company will present at the Bank of America Merrill Lynch Global Health Care Conference on Thursday, September 18, 2014, in London.
Top News: Bristol-Myers Squibb Company (NYSE:BMY), United States Steel ...  Equities Focus (registration)
Insider Selling: Bristol-Myers Squibb SVP Sells 7415 Shares of Stock (BMY)  WKRB News
Related articles »  
Bristol-Myers Squibb Becomes #111 Most Shorted S&P 500 Component ...
In our new rank based on the most recent short interest data from NASDAQ, Bristol-Myers Squibb Co. (NYSE: BMY) has taken over the position of #111 most shorted S&P 500 component, from Vulcan Materials Co (NYSE: VMC) which is now in the #220 spot.
Related articles »  
Why Making Dramatic Moves: Bristol-Myers Squibb Company (NYSE:BMY ...
Bristol-Myers Squibb Company (NYSE:BMY) COO Giovanni Caforio sold 26,691 shares of the company's stock in a transaction dated Monday, September 15th.